“We always spend December planning,” a biotech COO told us, “but when January arrives, we’re still in meetings...
“We always spend December planning,” a biotech COO told us, “but when January arrives, we’re still in meetings...
As 2025 wraps up, many organizations rush to close the books — but few pause to consider what...
As we close out 2025 and look ahead to a new year, leaders have an opportunity to reflect...
As pharmaceutical account teams race to close out the year, Q4 often exposes breakdowns in collaboration, coordination, and...
As the first quarter of 2025 concludes, life sciences organizations assess their progress. The 3C's Framework—collaboration, coordination, and...
Women leaders in the pharmaceutical industry drive innovation and enhance patient outcomes, yet they remain underrepresented in leadership...
At the start of the year, many companies pull their teams together for regional or national sales meetings...
As the year winds down, commercial leaders must balance hitting year-end targets while planning for 2025. This period...
As commercial leaders in pharma, biotech, and medical devices, we often face a unique challenge during the summer...
How did WLH help Myovant Sciences integrate development and performance into the company's culture?
As the days tick by, it is important to ask, "What needs to happen to close out the...
Learning pros, ideally, should be involved early to drive change.